Vascular function, insulin resistance and fatty acids

Diabetologia

Volumn 45, Issue 5, 2002, Pages 623-634

  Steinberg, H ^a   Baron, A ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Blood flow; Endothelial; Fatty acids; Insulin; Metabolism; Nitric oxide

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; DIABETIC OBESITY; ESTERIFICATION; FATTY ACID BLOOD LEVEL; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASODILATATION; ANIMAL; BLOOD FLOW; BLOOD VESSEL; DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ANIMAL; BLOOD VESSELS; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; ENDOTHELIUM, VASCULAR; FATTY ACIDS, NONESTERIFIED; HUMAN; INSULIN RESISTANCE; MUSCLE, SKELETAL; OBESITY IN DIABETES; REFERENCE VALUES; REGIONAL BLOOD FLOW; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY;

EID: 0035985081     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0800-2     Document Type: Review

References (75)

1. Insulin receptors and insulin action in the brain: Review and clinical implications
2. Insulin receptors and insulin actions in the nervous system
3. Insulin-stimulated insulin secretion in single pancreatic beta cells
4. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes
5. Hemodynamic actions of insulin
6. Obesity and insulin resistance
7. Insulin resistance in polycystic ovarian syndrome
8. Insulin resistance and coronary heart disease
9. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris prospective study, 15-year follow-up
10. Insulin-resistance, hypertriglyceridaemia and cardiovascular risk: The Paris prospective study
11. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines
12. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men
13. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans
14. Nitric oxide release accounts for insulin's vascular effects in humans
15. Kinetics of glucose disposal in whole body and across the forearm in man
16. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects
17. Insulin differentially regulates systemic and skeletal muscle vascular resistance
18. Evidence for physiological coupling of insulin-mediated glucose metabolism and limb blood flow
19. Effect of perfusion rate on the time course of insulin mediated skeletal muscle glucose uptake
20. Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects
21. Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction
22. + exchange by insulin in the human forearm
23. Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: Evidence for capillary recruitment
24. Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension
25. Insulin resistance and vasodilation in essential hypertension. Studies with adenosine
26. Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [150]water, and [18F]fluoro-deoxy-glucose and positron emission tomography
27. Insulin stimulates laser Doppler signal by rat muscle in vivo, consistent with nutritive flow recruitment
28. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha
29. Hemodynamic actions of insulin in rat skeletal muscle. Evidence for capillary recruitment
30. Acute vasoconstriction-induced insulin resistance in rat muscle in vivo
31. Insulin-induced vasodilation: Physiology or pharmacology?
32. Insulin-mediated vasodilation: Why one's physiology could be the other's pharmacology
33. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
34. The discovery of nitric oxide as the endogenous vasodilator
35. Nitric Oxide - A novel signal transduction mechanism for transcellular communication
36. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
37. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent
38. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans
39. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM
40. Insulin stimulates both endothelin and nitric oxide activity in the human forearm
41. Pharmacological modulation of endothelial function by insulin in the rat aorta
42. Endothelial function and adrenergic reactivity in human type-II diabetic resistance arteries
43. Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells
44. Insulin increases vascular smooth muscle recovery from intracellular calcium loads
45. Insulin stimulated production of nitric oxide is inhibited by Wortmannin. Direct measurement in vascular endothelial cells
46. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells
47. Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation
48. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
49. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin
50. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM
51. Insulin mediated nitric oxide production is impaired in insulin resistance
52. Coronary vasomotor responses to acetylcholine relates to risk factors for coronary artery disease
53. Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease
54. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
55. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease
56. Body weight and mortality among women
57. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
58. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study
59. Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus
60. Type II diabetes abrogates sex differences in endothelial function in premenopausal women
61. The fetal insulin hypothesis: An alternative explanation of the association of low birthweight with diabetes and vascular disease
62. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
63. Vascular wall function in insulin-resistant JCR:LA-cp rats: Role of male and female sex
64. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats
65. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus
66. Fatty acids and insulin resistance
67. Mechanism of free fatty acid-induced insulin resistance in humans
68. Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylation
69. Pharmcokinetics of amiodarone: Implications for drug therapy
70. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production
71. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity
72. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
73. Plasma free fatty acids and endothelium-dependent vasodilation: Effect of chain-length and cyclooxygenase inhibition
74. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease
75. Fatty acids impair nitric oxide production in cultured endothelial cells